Patents
Literature
Hiro is an intelligent assistant for R&D personnel, combined with Patent DNA, to facilitate innovative research.
Hiro

298 results about "Thianaphthene" patented technology

Thianaphthene may be used in the preparation of 2-thianapthenylphenyllith ium, via metalation by n-butyllithium. General description Reaction of ethyl diazoacetate with thianaphthene has been reported.

Nitric oxide releasing oxindole prodrugs for anagesic, Anti-inflammatory and disease-modifying use

Nitric oxide releasing oxindole prodrugs are described which are useful in methods of treating or preventing pain, inflammation, fever, or gastrointestinal lesions in a patient in need of such treatment, or of modifying an inflammatory disease or condition by favorably affecting the outcome thereof in said patient, wherein there is administered to said patient a therapeutically effective amount of a compound of Formula (I): and pharmaceutically acceptable salts thereof. In preferred embodiments, X is a covalent bond; RA and RB are both hydrogen; n is the integer 4; Y is -O-; Z is -NO2; RC is a member selected from the group consisting essentially of 5-Cl and 5-F; RD is a member selected from the group consisting essentially of 6-Cl and 6-F; and RE is a member selected from the group consisting essentially of benzyl, 2-furyl, 2-thienyl, 5-chloro-2-thienyl and 5-trifluoromethyl-2-thienyl.
Owner:PFIZER INC +1

Phosphorescent luminescent materials and preparation method and application thereof

The invention discloses phosphorescent luminescent materials and a preparation method and application thereof. The invention is characterized in that the phosphorescent luminescent materials are red light materials containing a metal iridium complex; a structural general formula of the phosphorescent luminescent materials is shown in the specification; and in the structural general formula, R1 and R2 are independently one of alkyl, phenyl, halogen-substituted phenyl, alkyl-substituted phenyl, naphthyl, anthryl, a halogen substituent, methoxy, phenoxy, cyano-substituted carbazolyl, substituted N-phenylcarbazolyl, quinolyl, thiazolyl, thienyl, an aromatic amino group, a group with an azole structure, an aromatic heterocyclic radical, a substituted aromatic heterocyclic radical and a silicon alkyl substituent respectively. The phosphorescent materials have high luminous efficiency; and the high luminous efficiency shows that the compounds can be taken as luminescent materials or main luminescent materials and applied to electroluminescent devices. Through data test and comparison, the materials are organic electroluminescent materials which have excellent performance and a good prospect, and particularly are phosphorescent red light materials which have good performance; and moreover, a method for synthesizing the luminescent materials is simple and low in cost.
Owner:JILIN OPTICAL & ELECTRONICS MATERIALS

Fungicides for the control of take-all disease of plants

A method of controlling Take-All disease of plants by applying a fungicide of the formula wherein Z1 and Z2 are C and are part of an aromatic ring which is [benzothiophene]thiophene; and A is [selected from] -C(X)-amine [wherein the amine is an unsubstituted, monosubstituted or disubstituted amino radical]wherein the amine is a monosubstituted or a disubstituted amine, wherein one of the substituents has a cyclic moiety, said cyclic moiety which is chosen from the group consisting of thienyl, furanyl, and a non-heterocyclic substituent, wherein when the amine is disubstituted, the second substituent is a non-cyclic substituent, -C(O)-SR3, -NH-C(X)R4, [and] or -C(=NR3)-XR7; B is -Wm-Q(R2)3 or selected from [O-tolyl]o-tolyl, 1-naphthyl, 2-naphthyl, and 9-phenanthryl, each optionally substituted with halogen or R4; Q is C, Si, Ge, or Sn; W is -C(R3)pH(2-p)-; or when Q is C, W is selected from [-C(R3)pH(2-p),[-C(R3)pH(2-p)-, -N(R3)mH(1-m)-, [-S(O)p-,] -S(O)p-, and -O-, X is [0] O or S; n is [0, 1, 2, or 3]2; m is 0 or 1; p is 0, 1, or 2; wherein the two R groups are combined with the thiophene ring to form a fused ring which is benzothiophene; each R and R2 is independently defined herein; R3 is C1-C4 alkyl; R4 is C1-C4 alkyl, haloalkyl, alkoxy, alkylthio, alkylamino, or dialkylamino; and R7 is C1-C4 alkyl, haloalkyl, or phenyl, optionally substituted with halo, nitro, or R4; or an agronomic salt thereof.
Owner:MONSANTO TECH LLC

Process for preparing a 4,7-bis(5-halothien-2-yl)-2,1,3-benzothiadiazole and a precursor therefor

The present invention is directed to a method for preparing a 4,7-bis(5-halothien-2-yl)-2,1,3-benzothiadiazole, more particularly, 4,7-bis(5-bromothien-2-yl)-2,1,3-benzothiadiazole, and a precursor therefor, namely, a 4,7-bis(thien-2-yl)-2,1,3-benzothiadiazole. The precursor is prepared by contacting in the presence of a palladium catalyst and a solvent a 4,7-dihalo-2,1,3-benzothiadiazole with a thienyl group adding reagent, which can either be a 2-thienylzinc halide, a 2-thienylmagnesium halide, or a 2-thiopheneboronic acid, under such conditions as to form 4,7-bis(thien-2-yl)-2,1,3-benzothiadiazole. The precursor can then be halogenated, preferably brominated, to form the desired dibrominated product, which is a particularly suitable monomer for the preparation of a copolymer of a 9,9-disubstituted fluorene. This copolymer is useful, for example, in polymeric light emitting diode (pLED) applications.
Owner:SUMITOMO CHEM CO LTD

Pharmaceutical composition comprising rotigotine salts (acid or na), especially for iontophoresis

InactiveUS20120101146A1Enhanced iontophoretic deliveryGood to excellent solubilityBiocideElectrotherapyRotigotineDrug
The present invention relates to new salts of 6-(propyl-(2-thiophen-2-ylethyl)amino)tetralin-1-ol (rotigotine), their use as a medicament, for example for the treatment of CNS disorders like Parkinson Disease, RLS, fybromyalgia and / or depression, in particular through electromotive administration. The present invention relates to pharmaceutical formulations suitable for iontophoresis that provide enhanced iontophoretic delivery of rotigotine to at least one target tissue. The formulations are further characterized by good to excellent solubility of the salts in aqueous solutions.
Owner:UCB SA

Fungicidal Mixtures of Thiophene Derivative

Disclosed are fungicidal mixtures, compositions and methods for controlling plant diseases relating to combinations comprising (a) N-[2-(1,3-dimethyl-butyl)-3-thienyl]-1-methyl-3-(tri-fluoromethyl)-1H-pyrazole-4 carboxamide (including all stereoisomers) or an agriculturally suitable salt thereof; and (b) at least one compound selected from the group consisting of compounds of Formula III or Formula IV which act at the bcl complex of the fungal mitochondrial respiratory electron transfer site; (INSERT FORMULA III HERE) (INSERT FORMULA IV HERE) wherein W, A, B, D and R5? are disclosed in this specification, and agriculturally suitable salts thereof; and optionally (c) at least one compound selected from the group of compounds acting at the demethylase enzyme of the sterol biosynthesis pathway and agriculturally suitable salts thereof.
Owner:EI DU PONT DE NEMOURS & CO

Novel chalcogen-containing organic compound and use thereof

[Problem] To provide an organic compound that is easy to synthesize, and has excellent chemical stability, semiconductor characteristics (high carrier mobility) and high solubility in a solvent.[Solution] A compound represented by formula (1) or formula (2):wherein, in formula (1), X is oxygen, sulfur or selenium; n is 0 or 1; R1 to R3 are hydrogen, fluorine, alkyl having 1 to 20 carbons, aryl, pyridyl, furyl, thienyl, thiazolyl or the like. However, except for a case where X is selenium, a case where all of R1 to R3 are simultaneously hydrogen is excluded, and a case where X is sulfur and all of R1 are simultaneously butyl is also excluded. In formula (2), X is oxygen, sulfur or selenium; n is 0 or 1; R1 to R2 are hydrogen, alkyl having 1 to 20 carbons, aryl, pyridyl, furyl, thienyl, thiazolyl or the like; however, a case where all of R1 to R2 are simultaneously hydrogen is excluded.
Owner:JNC CORP

Flavone analog, preparation and application thereof as anti-diabetic medicament

The invention discloses a flavone analog and application of a pharmaceutically acceptable salt thereof to preparation of an anti-diabetic medicament. The flavone analog has a structure shown by a formula I-X or II-X, wherein R1 in the formula I-X or II-X is selected from a substituted phenyl group, a substituted or unsubstituted furan group and a substituted or unsubstituted thienyl group and the substituent group is selected from a C1-4 alkyl group, a C1-4 alkoxyl group, halogen, a hydroxyl group and a cyano group; R2 is selected from the substituted phenyl group, the substituted or unsubstituted furan group and the substituted or unsubstituted thienyl group and the substituent group is selected from the halogen, the hydroxyl group and the cyano group.
Owner:TIANJIN MEDICAL UNIV

Compound, display panel and display device

The invention provides a compound, a display panel and a display device. The compound has the structure shown in formula (I), L represents substituted or unsubstituted phenyl, naphthyl, pyridyl, pyrimidinyl and pyrazinyl; D is an electron-donating group and independently selected from any one of substituted or unsubstituted phenyl, biphenyl, naphthyl, anthryl, phenanthryl, acenaphthylene, pyrenyl,peryl, flurenyl, spiro bifluorenyl, benzophenanthryl, benzanthracene, fluoranthryl, picene, furyl, benzofuryl, dibenzofuryl, thienyl, benzothienyl, dibenzothienyl, phenoxazine, thianthryl, carbazolyl, acridinyl and diarylamino. The designed compound has a TADF characteristic and can emit light by triplet exciton of traditional fluorescence molecular transition inhibition so as to improve the device efficiency.
Owner:WUHAN TIANMA MICRO ELECTRONICS CO LTD

Preparation method of arotinolol hydrochloride

The invention relates to a preparation method of arotinolol hydrochloride. The preparation method comprises the following steps: (1) preparing 2-[2,3-glycidyl-4-(5-carbamyl-2-thienyl)] thiazole; (2) dissolving 2-[2,3-glycidyl-4-(5-carbamyl-2-thienyl)] thiazole in absolute ethyl alcohol, adding tert-butylamine and performing a reflux reaction to obtain arotinolol; and (3) dissolving arotinolol in dimethyl sulfoxide and then adding concentrated hydrochloric acid to generate the arotinolol hydrochloride. The preparation method disclosed by the invention is short in production period, simple in process, high in yield, safe and reliable, and the arotinolol hydrochloride prepared by the method disclosed by the invention is high in purity.
Owner:SHIJIAZHUANG GERUI PHARMA CO LTD

Thienyl polymer-containing polymer photocatalyst with high photocatalytic water splitting hydrogen production activity and preparation method thereof

The invention discloses a thienyl polymer-containing photocatalyst with high photocatalytic water splitting hydrogen production activity and a preparation method thereof. The photocatalyst is prepared by adopting a simple ternary copolymerization Suzuki coupling reaction, and the construction unit of the photocatalyst comprises pyrene, thiophene or thiophene derivative and dibenzothiophene sulfone. The pyrenyl monomer and the dibenzothiophene sulfuryl monomer for polymerization have the same polymerizable functional groups and can be subjected to Suzuki coupling reaction with thiophene or thiophene derivative monomers at the same time so as to ensure that pyrenyl units and dibenzothiophene sulfuryl units in the polymer structure are connected through thiophene or thiophene derivative units. The polymer photocatalyst has the characteristics of high photocatalytic hydrogen production activity, high apparent quantum efficiency, narrow optical band gap and continuous and adjustable structure and composition, is simple in preparation process, high in yield and stable in performance, can release hydrogen under sunlight, and can be used in the field of photocatalytic hydrogen production.
Owner:SHAANXI NORMAL UNIV

Antineoplastic medicament antifolate, its salt and midbody

The invention discloses an antifolic for anti-tumor therapy, a relative salt and intermediate, wherein the antifolic and relative salt are represented as below, R1=NH2, R2=CH3, or R1=NHCH3 and R2=H, Ar is 1, 4-phenyl or 2, 5-thiofuran, R3 is H, metal cation, ammonium ion, or organic ammonium cation. The invention further discloses an application of the antifolic and relative salt for preparing anti-cancer drug. The inventive antifolic and relative salt have significant growth restraining activity on multiple tumor cells.
Owner:SHANGHAI JIAO TONG UNIV

Thiophene compound having sulfonyl group and process for producing the same

A thiophene compound having sulfonyl groups which is represented by the formula [1]. It has high heat resistance and high unsusceptibility to oxidation and can improve solubility and dispersibility in various solvents. [In the formula, R1 and R2 each independently represents hydrogen, halogeno, cyano, etc.; and R3 and R3' each independently represents C1-20 alkyl, C1-20 haloalkyl, phenyl optionally substituted by W, thienyl optionally substituted by W, etc. (W represents chlorine, etc.)].
Owner:NISSAN CHEM CORP
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products